Florida Senate - 2026 SB 886
By Senator Rodriguez
40-01022-26 2026886__
1 A bill to be entitled
2 An act relating to discounted drug pricing study;
3 requiring the Agency for Health Care Administration to
4 conduct or contract for a specified study; providing
5 requirements for the study; requiring the agency to
6 provide the results to the Governor and the
7 Legislature by a specified date; providing an
8 effective date.
9
10 Be It Enacted by the Legislature of the State of Florida:
11
12 Section 1. (1) The Agency for Health Care Administration
13 shall conduct or contract for a detailed fiscal impact study to
14 determine the feasibility of implementing the following
15 provisions relating to discounted drug prices under the 340B
16 Drug Pricing Program:
17 (a)1. Requiring drug manufacturers to sell a drug to
18 Medicaid pharmacies at no more than the 340B Drug Pricing
19 Program discounted price if the drug is:
20 a. On the Medicaid preferred drug list as described in s.
21 409.912(5), Florida Statutes.
22 b. A covered drug under the 340B Drug Pricing Program.
23 2. Authorizing drug manufacturers to deliver drugs sold in
24 accordance with subparagraph 1. to the purchasing Medicaid
25 pharmacy by any method used by the drug manufacturer.
26 3. If a drug manufacturer sells a drug in accordance with
27 subparagraph 1. to a Medicaid pharmacy at the 340B Drug Pricing
28 Program discounted price and such discounted price is higher
29 than the state Medicaid negotiated price, requiring the drug
30 manufacturer to pay a rebate to the state equal to the
31 difference between the discounted price and the state Medicaid
32 negotiated price.
33 (b) Requiring pharmacy benefits managers participating in
34 the Medicaid program to pay a Medicaid pharmacy the 340B Drug
35 Pricing Program discounted price plus the professional
36 dispensing fee as determined under rule 59G-4.251, Florida
37 Administrative Code, as amended, for any drug that is on the
38 Medicaid preferred drug list as described in s. 409.912(5),
39 Florida Statutes, and that is a covered drug under the 340B Drug
40 Pricing Program.
41 (c)1. Requiring drug wholesalers and distributors to sell a
42 drug to a Medicaid pharmacy at the 340B Drug Pricing Program
43 discounted price if the drug is:
44 a. On the Medicaid preferred drug list as described in s.
45 409.912(5), Florida Statutes.
46 b. A covered drug under the 340B Drug Pricing Program.
47 2. Prohibiting drug wholesalers and distributors from
48 changing an existing pricing model or program that is in place
49 with a Medicaid pharmacy by exempting a drug described in
50 paragraph (a) from the pricing model or program or by
51 referencing such drug in any way in the pricing model or
52 program.
53 (d) Requiring Medicaid pharmacies to provide a covered drug
54 under the 340B Drug Pricing Program at the discounted price only
55 to Medicaid recipients.
56 (2) The agency shall submit the results of the study to the
57 Governor, the President of the Senate, and the Speaker of the
58 House of Representatives by January 31, 2027.
59 Section 2. This act shall take effect July 1, 2026.